Spitfire Pharma

About:

Spitfire Pharma offers drug development and research services that improve the pharmaceutical properties of peptide drugs.

Top Investors: CMEA Capital

Description:

Spitfire Pharma, Inc. offers drug development and research services to improve the pharmaceutical properties of peptide drugs. The company was founded in 2011 and is based in South San Francisco, California.

Total Funding Amount:

$500000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2011-01-01

Founders:

John Nestor

Number of Employees:

11-50

Last Funding Date:

2013-04-01

IPO Status:

Private

Industries: